HenggeUR, RuzickaT, TyringSKet al.Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 2: Pathogenesis, Castleman's disease, and pleural effusion lymphoma. Lancet Infect Dis, 2002; 2:344–352.
2.
DezubeBJ, PantanowitzL, AboulafiaDM. Management of AIDS-related Kaposi sarcoma: Advances in target discovery and treatment. AIDS Read, 2004; 14:236–238.
3.
de WitR, SchattenkerkJK, BoucherCA, BakkerPJ, VeenhofKH, DannerSA. Clinical and virological effects of high-dose recombinant Interferon-alpha in disseminated AIDS-related Kaposi's sarcoma. Lancet, 1988; 332:1214–1217.
Di LorenzoG, KonstantinopoulosPA, PantanowitzL, Di TrolioR, De PlacidoS, DezubeBJ. Management of AIDS-related Kaposi's sarcoma. Lancet Oncol, 2007; 8:167–176.
6.
JonesJL, HansonDL, DworkinMS, WardJW, JaffeHW. Effect of antiretroviral therapy on recent trends in selected cancers among HIV-infected persons. Adult/Adolescent Spectrum of HIV Disease Project Group. J Acquir Immune Defic Syndr, 1999; 21:S11–S17.
7.
IbekwePU, OgunbiyiOA, OgunGO, GeorgeOA. Kaposi's sarcoma in HIV-infected women and men in Nigeria. AIDS Patient Care STDS, 2011; 25:635–637.
8.
KrownSE, LeeJY, LinL, FischlMA, AmbinderR, Von RoennJH. Interferon-alpha2b with protease inhibitor-based antiretroviral therapy in patients with AIDS-associated Kaposi sarcoma: An AIDS malignancy consortium phase I trial. J Acquir Immune Defic Syndr, 2006; 41:149–153.
9.
van der EndeM, MulderJW, van den BergeM, BlokW, SchuttenM. Complete clinical and virological remission of refractory HIV-related Kaposi's sarcoma with pegylated interferon alpha. AIDS, 2007; 21:1661–1662.
10.
VogtMW, DurnoAG, ChouTCet al.Synergistic interaction of 2’,3’-dideoxycytidine and recombinant interferon-alpha-A on replication of human immunodeficiency virus type 1. J Infect Dis, 1988; 158:378–385.
11.
WuW, RochfordR, ToomeyL, HarringtonWJr, FeuerG. Inhibition of HHV-8/KSHV infected primary effusion lymphomas in NOD/SCID mice by azidothymidine and interferon-alpha. Leuk Res, 2005; 29:545–555.
12.
Von MarschallZ, ScholzA, CramerTet al.Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis. J Natl Cancer Inst, 2003; 95:437–448.
13.
ParmarS, SmithJ, SassanoAet al.Differential regulation of the p70 S6 kinase pathway by interferon a (IFNa) and imatinib mesylate (STI571) in chronic myelogenous leukemia cells. Blood, 2006; 106:2436–2443.
